Study: Oncologists who take pharma money are more likely to provide low-value treatments
Oncologists were more likely to provide low-value cancer drugs to their patients after receiving personal payments from pharma companies than those who did not receive …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
